PD52-03 GENETIC MUTATIONS AS PREDICTIVE BIOMARKERS IN METASTATIC RENAL CELL CARCINOMA

Logan Briggs,Eugene B. Cone,Michael L. Blute

PD52-03 GENETIC MUTATIONS AS PREDICTIVE BIOMARKERS IN METASTATIC RENAL CELL CARCINOMA

2021

Logan Briggs
Eugene B. Cone
Michael L. Blute

INTRODUCTION AND OBJECTIVE:Advancements in treatment strategies for metastatic renal cell carcinoma (mRCC) have led to a great variety of available targeted, immune checkpoint inhibitor (ICI), and ...

Keywords:

Cancer research
Medicine
Renal cell carcinoma
treatment strategy
predictive biomarker
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations